US Stock MarketDetailed Quotes

OPT Opthea

Watchlist
  • 3.340
  • +0.110+3.41%
Close Dec 20 16:00 ET
514.00MMarket Cap-1.21P/E (TTM)

About Opthea Company

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.

Company Profile

SymbolOPT
Company NameOpthea
Issue Price13.50
Founded1984
CEODr. Frederic Guerard, Pharm.D.
MarketNASDAQ
Employees34
Securities TypeDR
ADS Ratio1.0 : 8.0
Fiscal Year Ends06-30
Address650 Chapel Street,Suite 0403,Level 4
CitySouth Yarra
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3141
Phone61-3-9826-0399

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Frederic Guerard, Pharm.D.
  • Chief Executive Officer
  • 1.32M
  • Judith J. Robertson
  • Chief Commercial Officer
  • 715.10K
  • Peter F. Lang
  • Chief Financial Officer
  • 1.16M
  • Dr. Megan Baldwin
  • Chief Innovation Officer and Executive Director
  • 1.36M
  • Julie Clark
  • Senior Vice President, Clinical Development
  • --
  • Bruno Gagnon
  • Senior Vice President, Global Clinical Operations
  • --
  • Karen Adams
  • Vice President, Finance and Company Secretary
  • 466.17K
  • Dr. John Han
  • Vice President, Medical Affairs
  • --
  • Kevin Bitter
  • Vice President, Strategy & Corporate Development
  • --
  • Fang Li, PhD
  • Senior Vice President, Regulatory
  • --
  • Mark O Neill
  • Vice President, Chemistry, Manufacturing and Controls
  • --
  • Jeremy M. Levin, D.Phil.,M.B.
  • Chairman of the Board
  • 309.43K
  • Anshul Thakral
  • Director
  • 103.72K
  • Dr. Julia A. Haller, M.D.
  • Director
  • 170.25K
  • Sujal Shah
  • Independent Director
  • 16.72K
  • Susan Orr
  • Independent Director
  • 130.26K
  • Lawrence B. Gozlan
  • Independent Director
  • 790.52K
  • Quinton Oswald
  • Independent Director
  • 135.81K
Heat List
US
Overall
Symbol
Price
% Chg

No Data